Found: 37
Select item for more details and to access through your institution.
Primary Founder Mutations in the PRKDC Gene Increase Tumor Mutation Load in Colorectal Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 2, p. 633, doi. 10.3390/ijms23020633
- By:
- Publication type:
- Article
Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 1, p. 196, doi. 10.3390/ijms19010196
- By:
- Publication type:
- Article
Real-world use of multigene signatures in early breast cancer: differences to clinical trials.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 205, n. 1, p. 39, doi. 10.1007/s10549-023-07227-0
- By:
- Publication type:
- Article
Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1374547
- By:
- Publication type:
- Article
Establishing the Evidence Bar for Molecular Diagnostics in Personalised Cancer Care.
- Published in:
- Public Health Genomics, 2015, v. 18, n. 6, p. 349, doi. 10.1159/000441556
- By:
- Publication type:
- Article
Use of Formalin-Fixed Paraffin-Embedded Samples for Gene Expression Studies in Breast Cancer Patients.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0123194
- By:
- Publication type:
- Article
Accurate Data Processing Improves the Reliability of Affymetrix Gene Expression Profiles from FFPE Samples.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086511
- By:
- Publication type:
- Article
Immunotherapy for early triple negative breast cancer: research agenda for the next decade.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00386-1
- By:
- Publication type:
- Article
Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-021-00377-8
- By:
- Publication type:
- Article
Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092136
- By:
- Publication type:
- Article
Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1898, doi. 10.3390/cancers14081898
- By:
- Publication type:
- Article
Emetogenicity of Antibody-Drug Conjugates (ADCs) in Solid Tumors with a Focus on Trastuzumab Deruxtecan: Insights from an Italian Expert Panel.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 1022, doi. 10.3390/cancers14041022
- By:
- Publication type:
- Article
PET/MRI for Staging the Axilla in Breast Cancer: Current Evidence and the Rationale for SNB vs. PET/MRI Trials.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3571, doi. 10.3390/cancers13143571
- By:
- Publication type:
- Article
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 12, p. 2355, doi. 10.1002/1878-0261.13141
- By:
- Publication type:
- Article
Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 1, p. 39, doi. 10.1007/s10549-017-4502-3
- By:
- Publication type:
- Article
Assessing cost-utility of predictive biomarkers in oncology: a streamlined approach.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 155, n. 2, p. 223, doi. 10.1007/s10549-016-3677-3
- By:
- Publication type:
- Article
First generation prognostic gene signatures for breast cancer predict both survival and chemotherapy sensitivity and identify overlapping patient populations.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 130, n. 1, p. 155, doi. 10.1007/s10549-011-1706-9
- By:
- Publication type:
- Article
Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 125, n. 3, p. 785, doi. 10.1007/s10549-010-1280-6
- By:
- Publication type:
- Article
Development and validation of a gene expression-based Breast Cancer Purity Score.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00730-7
- By:
- Publication type:
- Article
Prognostic significance of a signature based on senescence-related genes in colorectal cancer.
- Published in:
- GeroScience, 2024, v. 46, n. 5, p. 4495, doi. 10.1007/s11357-024-01164-6
- By:
- Publication type:
- Article
Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2021.827625
- By:
- Publication type:
- Article
Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Completion Rate and Positive Results Reporting Among Immunotherapy Trials in Breast Cancer, 2004-2023.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 7, p. e2423390, doi. 10.1001/jamanetworkopen.2024.23390
- By:
- Publication type:
- Article
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 12, p. 2025, doi. 10.1038/s41416-023-02477-7
- By:
- Publication type:
- Article
Utility of Oncotype DX Risk Estimates in Clinically Intermediate Risk Hormone Receptor-Positive, HER2-Normal, Grade II, Lymph Node-Negative Breast Cancers.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 22, p. 5161, doi. 10.1002/cncr.25269
- By:
- Publication type:
- Article
Personalized Risk–Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID‐19 Outbreak.
- Published in:
- Oncologist, 2020, v. 25, n. 7, p. e1013, doi. 10.1634/theoncologist.2020-0316
- By:
- Publication type:
- Article
DNA Repair Gene Patterns as Prognostic and Predictive Factors in Molecular Breast Cancer Subtypes.
- Published in:
- Oncologist, 2013, v. 18, n. 10, p. 1063, doi. 10.1634/theoncologist.2013-0163
- By:
- Publication type:
- Article
Breast Cancer Genomics: Challenges in Interpretation and Application.
- Published in:
- Oncologist, 2013, v. 18, n. 4, p. e11, doi. 10.1634/theoncologist.2013-0116
- By:
- Publication type:
- Article
Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1081885
- By:
- Publication type:
- Article
Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 01, doi. 10.3389/fonc.2022.1032166
- By:
- Publication type:
- Article
Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approach.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.950861
- By:
- Publication type:
- Article
Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients.
- Published in:
- Cancer Science, 2016, v. 107, n. 12, p. 1730, doi. 10.1111/cas.13101
- By:
- Publication type:
- Article
HER2-Directed T-Cell Receptor–Mimicking Antibody: A “Me Too” or an Example of Novel Antitumor Aggressive Mimicry?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 3, p. 161, doi. 10.1093/jnci/djs636
- By:
- Publication type:
- Article
Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 3, p. 264, doi. 10.1093/jnci/djq524
- By:
- Publication type:
- Article
OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 7, p. 1196, doi. 10.1016/j.molonc.2014.04.003
- By:
- Publication type:
- Article
TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 3, p. 508, doi. 10.1016/j.molonc.2013.12.018
- By:
- Publication type:
- Article